Retracted: 'Anti-fibrotic actions of Ghrelin by inhibition of the NADPH oxidase-ROS signaling pathway' by Qian Wang, Xin Sui, Rui Chen, Peiyong Ma, Tao Ding, Dianjun Sui, and Ping Yang.

Author unknown

Open source

DOI
10.1111/1440-1681.12948
Published
2018 Aug
Container
Clinical and experimental pharmacology & physiology
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/1440-1681.12948,
  title = {Retracted: 'Anti-fibrotic actions of Ghrelin by inhibition of the NADPH oxidase-ROS signaling pathway' by Qian Wang, Xin Sui, Rui Chen, Peiyong Ma, Tao Ding, Dianjun Sui, and Ping Yang.},
  year = {2018},
  journal = {Clinical and experimental pharmacology \& physiology},
  doi = {10.1111/1440-1681.12948},
  url = {https://doi.org/10.1111/1440-1681.12948}
}

RIS

TY  - JOUR
TI  - Retracted: 'Anti-fibrotic actions of Ghrelin by inhibition of the NADPH oxidase-ROS signaling pathway' by Qian Wang, Xin Sui, Rui Chen, Peiyong Ma, Tao Ding, Dianjun Sui, and Ping Yang.
PY  - 2018
JO  - Clinical and experimental pharmacology & physiology
DO  - 10.1111/1440-1681.12948
UR  - https://doi.org/10.1111/1440-1681.12948
ER  - 

APA

Retracted: 'Anti-fibrotic actions of Ghrelin by inhibition of the NADPH oxidase-ROS signaling pathway' by Qian Wang, Xin Sui, Rui Chen, Peiyong Ma, Tao Ding, Dianjun Sui, and Ping Yang.. (2018). Clinical and experimental pharmacology & physiology. https://doi.org/10.1111/1440-1681.12948

Source records